Your session is about to expire
← Back to Search
Stem Cell Transplant for Age-Related Macular Degeneration
Study Summary
This trial is testing if it is safe to put cells in people's eyes as a possible future treatment for dry age-related macular degeneration. People who have had "wet" macular degeneration in either eye are not eligible.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 55 years old or older.My study eye has a specific type of retina damage and meets the vision sharpness requirements.I am not willing or able to agree to participate in this or future studies.I have been diagnosed with AMD in at least one eye.I have conditions that make using steroids or immune treatments risky.My cancer diagnosis may impact my survival over the next two years.I have taken medication that could harm my eyes in the last year.My family has a history of eye diseases other than age-related macular degeneration.My study eye does not have conditions like neovascularization, glaucoma, or a history of eye surgery.My study eye is clear and has an artificial lens or no lens.I can attend all required study visits and follow the treatment plan.
- Group 1: Participants receiving intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are we still enrolling people in this clinical trial?
"Yes, this study is still recruiting patients according to the latest information on clinicaltrials.gov. The trial was originally posted on September 23rd 2020 but has been updated as recently as August 13th 2022."
How many participants are being allowed in this clinical trial?
"That is correct. The clinicaltrials.gov website notes that this research project is still recruiting individuals. This study was originally advertised on September 23rd 2020 with the latest update being on August 13th 2022. Right now, they are looking for 20 more participants and only have 1 site open."
What are the main goals that we hope to achieve with this experiment?
"The team conducting this trial will be evaluating the success of the intervention by measuring the Summary of adverse events over 12, 24, and 60 months. Additionally, they will also be looking at Retinal sensitivity and fixation (microperimetry), Retinal Structure (optical coherence tomography), and Retinal structure (fluorescein angiography) as safety and efficacy measures."
Share this study with friends
Copy Link
Messenger